NYSE:CLB Core Laboratories (CLB) Stock Price, News & Analysis $10.56 +0.03 (+0.25%) Closing price 08/4/2025 03:59 PM EasternExtended Trading$10.62 +0.06 (+0.56%) As of 04:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Core Laboratories Stock (NYSE:CLB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Core Laboratories alerts:Sign Up Key Stats Today's Range$10.37▼$10.6550-Day Range$10.53▼$13.3652-Week Range$10.14▼$21.83Volume656,672 shsAverage Volume459,254 shsMarket Capitalization$494.97 millionP/E Ratio17.03Dividend Yield0.38%Price Target$12.50Consensus RatingHold Company Overview Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas. Read More Core Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks45th Percentile Overall ScoreCLB MarketRank™: Core Laboratories scored higher than 45% of companies evaluated by MarketBeat, and ranked 367th out of 534 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingCore Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageCore Laboratories has only been the subject of 2 research reports in the past 90 days.Read more about Core Laboratories' stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth15.63% Earnings GrowthEarnings for Core Laboratories are expected to grow by 15.63% in the coming year, from $0.96 to $1.11 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 17.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.10.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 17.03, which means that it is trading at a less expensive P/E ratio than the Energy sector average P/E ratio of about 77.53.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 3.20. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 1.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Core Laboratories' valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.61% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 15, which indicates bearish sentiment.Change versus previous monthShort interest in Core Laboratories has recently increased by 3.63%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldCore Laboratories has a dividend yield of 0.38%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 6.45%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.60% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.Read more about Core Laboratories' dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted16.61% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 15, which indicates bearish sentiment.Change versus previous monthShort interest in Core Laboratories has recently increased by 3.63%, indicating that investor sentiment is decreasing. News and Social Media1.8 / 5News SentimentN/A News SentimentCore Laboratories has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Energy companies.News Coverage This WeekMarketBeat has tracked 1 news article for Core Laboratories this week, compared to 3 articles on an average week.MarketBeat Follows1 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.94% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Core Laboratories' insider trading history. Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address CLB Stock News HeadlinesPetrofac (OTCMKTS:POFCY) versus Core Laboratories (NYSE:CLB) Critical ContrastJuly 29, 2025 | americanbankingnews.comCore Laboratories (NYSE:CLB) Upgraded at Wall Street ZenJuly 29, 2025 | americanbankingnews.comTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now. | Crypto 101 Media (Ad)Core Labs Posts Flat Revenue in Q2July 28, 2025 | fool.comCore Laboratories (NYSE:CLB) Shares Gap Up on Better-Than-Expected EarningsJuly 26, 2025 | americanbankingnews.comCore Laboratories earnings missed by $0.13, revenue fell short of estimatesJuly 23, 2025 | investing.comCore Laboratories Inc (CLB) Q2 2025 Earnings: EPS at $0.22, Revenue Hits $130. ...July 23, 2025 | gurufocus.comCORE LAB REPORTS SECOND QUARTER 2025 RESULTSJuly 23, 2025 | prnewswire.comSee More Headlines CLB Stock Analysis - Frequently Asked Questions How have CLB shares performed this year? Core Laboratories' stock was trading at $17.31 at the beginning of 2025. Since then, CLB stock has decreased by 39.0% and is now trading at $10.5560. How were Core Laboratories' earnings last quarter? Core Laboratories Inc. (NYSE:CLB) released its earnings results on Wednesday, July, 23rd. The oil and gas company reported $0.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.18 by $0.01. The firm's quarterly revenue was down .3% on a year-over-year basis. Read the conference call transcript. Who are Core Laboratories' major shareholders? Top institutional investors of Core Laboratories include Envestnet Asset Management Inc. (0.60%), Arkadios Wealth Advisors (0.18%), Oppenheimer Asset Management Inc. (0.13%) and Exchange Capital Management Inc. (0.08%). View institutional ownership trends. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Record date for 5/27 Dividend5/05/2025Ex-Dividend for 5/27 Dividend5/05/2025Dividend Payable5/27/2025Last Earnings7/23/2025Record date for 8/25 Dividend8/04/2025Ex-Dividend for 8/25 Dividend8/04/2025Today8/05/2025Dividend Payable8/25/2025Next Earnings (Estimated)10/22/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorEnergy Industry OIL - FIELD SVCS Sub-IndustryPetroleum And Natural Gas Current SymbolNYSE:CLB CIK1000229 Webwww.corelab.com Phone(713) 328-2673FaxN/AEmployees3,500Year Founded1936Price Target and Rating Average Price Target for Core Laboratories$12.50 High Price Target$13.00 Low Price Target$12.00 Potential Upside/Downside+18.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)$0.62 Trailing P/E Ratio17.03 Forward P/E Ratio11.00 P/E Growth3.2Net Income$31.40 million Net Margins5.73% Pretax Margin8.24% Return on Equity14.15% Return on Assets6.18% Debt Debt-to-Equity Ratio0.47 Current Ratio2.27 Quick Ratio1.70 Sales & Book Value Annual Sales$523.85 million Price / Sales0.94 Cash Flow$1.18 per share Price / Cash Flow8.92 Book Value$5.49 per share Price / Book1.92Miscellaneous Outstanding Shares46,890,000Free Float46,453,000Market Cap$494.97 million OptionableOptionable Beta1.41 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NYSE:CLB) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.